The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients

Covid19 Clinical Trial

Official title:

The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04402983
• Other study ID #: Telerehab_Covid19
• Status: Completed
• Phase: N/A
• Start date: May 27, 2020
• Est. completion date: December 1, 2020

Study information

• Verified date: May 2020
• Source: Istanbul Medipol University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases.

Description:

Problems such as breathlessness, exercise intolerance and loss of peripheral muscle strength can be observed in individuals who have been diagnosed with COVID19 and have been discharged. In our study, it was aimed to investigate the effect of telerehabilitation physical therapy intervention to these cases by using videoconferencing method on the physical condition of the cases. The exercise program will be a total of 6 weeks, 3 days a week. Online access will be carried out synchronously by telephone or computer, and training sessions will not be recorded in order to protect patient personal information. The cases will be evaluated online at the beginning of the study and at the end of the 6-week exercise program. The selected evaluation parameters have been selected considering the ease of online application.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: December 1, 2020
• Est. primary completion date: December 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Being between the ages of 18-75
• Being diagnosed with COVID19 and being discharged by being treated
• Having technological facilities suitable for telerehabilitation access

Exclusion Criteria:

• Any presence of comorbidity that may prevent them from exercising
• Not agreeing to be included in the study

Related Conditions & MeSH terms

• Covid19
• Physical Therapy
• Telerehabilitation

Intervention

Other:
• Physiotherapy
Program content Respiratory exercise (chest breathing, diaphragmatic breathing, basal expansion exercises), Breath control training, Active breathing techniques cycle Light aerobic exercise Posture exercises Self walking

Locations

Country	Name	City	State
Turkey	University of Health Sciences Turkey	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modified Medical Research Council Dyspnea Score	The mMRC Dyspnea Scale is best used to establish baseline functional impairment due to dyspnea attributable to respiratory disease; tracking the mMRC over time or with therapeutic interventions is of less certain clinical utility.The severity of dyspnea is rated on a scale of 0 to 4. "O" means no dyspnea perception, "4" means severe dyspnea perception.	Baseline to 6 weeks
Primary	Timed up and go test	The Timed "Up and Go" (TUG) Test measures, in seconds, the time taken by an individual to stand up from a standard arm chair (approximate seat height of 46 cm, arm height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk back to the chair, and sit down.; Normal healthy elderly usually complete the task in 10 seconds or less. Very frail or weak elderly with poor mobility may take 2 minutes or more.; Clinical guide: <10 seconds = normal <20 seconds = good mobility, can go out alone, mobile without a gait aid <30 seconds = problems, cannot go outside alone, requires a gait aid A score of more than or equal to 14 seconds has been shown to indicate high risk of falls.	Baseline to 6 weeks
Primary	Visual analog scale to assess the pain severity	Visual analog scale to assess the pain on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.	Baseline to 6 weeks
Primary	The Short Physical Performance Battery (SPPB)	The Short Physical Performance Battery (SPPB) is comprised of 3 tasks: a standing balance test (side by side, semi-tandem and tandem), a 4-m habitual gait speed, and 5 sit to stand from a chair. Each task is scored (based on time) from 0-4 points. The total score is 12 points and this represents the highest performance. It can be easily performed at home via video conferencing	Baseline to 6 weeks
Primary	Visual analog scale to assess the fatigue severity	Visual analog scale to assess the fatigue severity on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100) score.	Baseline to 6 weeks
Secondary	BECK depression inventory	This is a 21-item self-assessment scale designed by Aaron Beck in 1961 to measure the risk and level of depression.	Baseline to 6 weeks
Secondary	Saint George Respiratory Questionnaire	The SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life)	Baseline to 6 weeks